Oscar Health Inc. (OSCR) Tops Q2 EPS by 15c

Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of ($0.07), $0.15 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.38 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Deutsche Bank Upgrades Kingfisher Plc. (KGF:LN) (KGFHY) to Hold
• Citizens Upgrades J.B. Hunt Transport Services (JBHT) to Market Outperform